These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33183187)

  • 41. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffusion and Flux Improvement of Drugs through Complexation.
    Mannava MKC; Garai A; Nangia AK
    Mol Pharm; 2023 May; 20(5):2293-2316. PubMed ID: 36974968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous engineering of nano-cocrystals for medical and energetic applications.
    Spitzer D; Risse B; Schnell F; Pichot V; Klaumünzer M; Schaefer MR
    Sci Rep; 2014 Oct; 4():6575. PubMed ID: 25300652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.
    Gadade DD; Pekamwar SS
    Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitigating Drug Stability Challenges Through Cocrystallization.
    Haneef J; Amir M; Sheikh NA; Chadha R
    AAPS PharmSciTech; 2023 Feb; 24(2):62. PubMed ID: 36759434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.
    Yadav AV; Dabke AP; Shete AS
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization and Quality Control of Pharmaceutical Cocrystals.
    Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
    Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
    Chaudhari KR; Savjani JK; Savjani KT; Shah H
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced methodologies for cocrystal synthesis.
    Douroumis D; Ross SA; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent developments in the use of nanocrystals to improve bioavailability of APIs.
    Ding Y; Zhao T; Fang J; Song J; Dong H; Liu J; Li S; Zhao M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1958. PubMed ID: 38629192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
    Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
    Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antisolvent coprecipitation method for enhanced bioavailability of poorly water-soluble drugs.
    Zhang J; Liu M; Zeng Z
    Int J Pharm; 2022 Oct; 626():122043. PubMed ID: 35902056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmaceutical Co-crystal of Antiviral Agent Efavirenz with Nicotinamide for the Enhancement of Solubility, Physicochemical Stability, and Oral Bioavailability.
    Yadav D; Savjani J; Savjani K; Kumar A; Patel S
    AAPS PharmSciTech; 2022 Nov; 24(1):7. PubMed ID: 36447108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.